BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, Hubscher S, Karkhanis S, Lester W, Roslund N, West R, Wyatt JI, Heydtmann M. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 2020;69:1382-403. [PMID: 32467090 DOI: 10.1136/gutjnl-2020-321299] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Pavic T, Mikolasevic I, Kralj D, Blazevic N, Skrtic A, Budimir I, Lerotic I, Hrabar D. Role of Endoscopic Ultrasound in Liver Disease: Where Do We Stand? Diagnostics (Basel) 2021;11:2021. [PMID: 34829368 DOI: 10.3390/diagnostics11112021] [Reference Citation Analysis]
2 Finer N. Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. Diabetes Obes Metab 2021. [PMID: 34622555 DOI: 10.1111/dom.14569] [Reference Citation Analysis]
3 Asai A, Yokohama K, Ohama H, Tsuchimoto Y, Fukunishi S, Higuchi K. Association between Administration of Antithrombotics and Intraperitoneal Hemorrhage in Patients Undergoing Percutaneous Interventions for Liver Diseases. J Clin Med 2021;10:2527. [PMID: 34200283 DOI: 10.3390/jcm10112527] [Reference Citation Analysis]
4 Zhong C, Jin J, Wang X, Huang Y, Yan D, Wang W. Effects of Different Recovery Positions on the Postpercutaneous Liver Biopsy Complications: A Metaanalysis. Front Surg 2021;8:707945. [PMID: 34778353 DOI: 10.3389/fsurg.2021.707945] [Reference Citation Analysis]
5 Cho SJ, Perito ER, Shafizadeh N, Kim GE. Dialogs in the assessment of neonatal cholestatic liver disease. Hum Pathol 2021;112:102-15. [PMID: 33359238 DOI: 10.1016/j.humpath.2020.12.007] [Reference Citation Analysis]
6 Flisiak R, Antonov K, Drastich P, Jarcuska P, Maevskaya M, Makara M, Puljiz Ž, Štabuc B, Trifan A. Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures. J Clin Med 2021;10:5419. [PMID: 34830701 DOI: 10.3390/jcm10225419] [Reference Citation Analysis]
7 Langford CR, Goldinger MH, Treanor D, McGenity C, Dillman JR, Allende DS, Goldin R, Brunt EM, Zatloukal K, Denk H, Fleming KA. Improved pathology reporting in NAFLD/NASH for clinical trials. J Clin Pathol 2021:jclinpath-2021-207967. [PMID: 34753791 DOI: 10.1136/jclinpath-2021-207967] [Reference Citation Analysis]
8 Zhong J, Allard R, Hewitson D, Weston M, Hulson O, Burbidge S, Lambie H, Kaye T, Wyatt JI, Albazaz R. A real-world study evaluating ultrasound-guided percutaneous non-targeted liver biopsy needle failures and pathology sample-quality assessment in both end-cut and side-notch needles. Br J Radiol 2021;94:20210475. [PMID: 34289324 DOI: 10.1259/bjr.20210475] [Reference Citation Analysis]
9 Behairy BE, Allam AAE, Hegazy SG, Taie DM, Sira AM. Adequacy criteria of Tru-cut needle liver biopsy in neonatal cholestasis. Ann Hepatol 2021;:100548. [PMID: 34600141 DOI: 10.1016/j.aohep.2021.100548] [Reference Citation Analysis]
10 Chetwood JD, Mudaliar S, Staudenmann D, Shin JS, Liu K, Majumdar A, Kaffes A, Strasser S, McCaughan GW, Saxena P. Emerging role of endoscopic ultrasound-guided liver biopsy. Gut 2020:gutjnl-2020-322704. [PMID: 32948619 DOI: 10.1136/gutjnl-2020-322704] [Reference Citation Analysis]
11 McKay A, Pantoja C, Hall R, Matthews S, Spalding P, Banerjee R. Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway. J Patient Rep Outcomes 2021;5:89. [PMID: 34508298 DOI: 10.1186/s41687-021-00363-5] [Reference Citation Analysis]
12 Facciorusso A, Crinò SF, Ramai D, Fabbri C, Mangiavillano B, Lisotti A, Muscatiello N, Cotsoglou C, Fusaroli P. Diagnostic yield of endoscopic ultrasound-guided liver biopsy in comparison to percutaneous liver biopsy: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2021;:1-7. [PMID: 34918578 DOI: 10.1080/17474124.2022.2020645] [Reference Citation Analysis]
13 Cerda Reyes E, González-Navarro EA, Magaz M, Muñoz-Sánchez G, Diaz A, Silva-Junior G, Triguero A, Lafoz E, Campreciós G, Orts L, Perez-Campuzano V, Seijo S, Rubio L, Turon F, Baiges A, Hernández-Gea V, Álvarez-Larran A, Juan M, Garcia-Pagan JC. Autoimmune biomarkers in porto-sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology. Liver Int 2021;41:2171-8. [PMID: 34173316 DOI: 10.1111/liv.14997] [Reference Citation Analysis]
14 Hadjittofi C, Feretis M, Martin J, Harper S, Huguet E. Liver regeneration biology: Implications for liver tumour therapies. World J Clin Oncol 2021; 12(12): 1101-1156 [DOI: 10.5306/wjco.v12.i12.1101] [Reference Citation Analysis]
15 Feldman AG, Squires JE, Hsu EK, Lobritto S, Mohammad S; SPLIT Education Committee, the Pediatric Transplant Hepatology Fellowship Program Directors. The current state of pediatric transplant hepatology fellowships: A survey of recent graduates. Pediatr Transplant 2021;:e14065. [PMID: 34120405 DOI: 10.1111/petr.14065] [Reference Citation Analysis]
16 Mendoza YP, Rodrigues SG, Delgado MG, Murgia G, Lange NF, Schropp J, Montani M, Dufour JF, Berzigotti A. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease. Liver Int 2022;42:102-11. [PMID: 34821035 DOI: 10.1111/liv.15116] [Reference Citation Analysis]
17 Amodu A, Porteny T, Schmidt IM, Ladin K, Waikar SS. Nephrologists' Attitudes Toward Native Kidney Biopsy: A Qualitative Study. Kidney Med 2021;3:1022-31. [PMID: 34939011 DOI: 10.1016/j.xkme.2021.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Czajka P, Przybyłkowski A, Nowak A, Postula M, Wolska M, Mirowska-Guzel D, Czlonkowska A, Eyileten C. Antiplatelet drugs and liver fibrosis. Platelets 2021;:1-10. [PMID: 33577391 DOI: 10.1080/09537104.2021.1883574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chen H, Dai S, Fang Y, Chen L, Jiang K, Wei Q, Ding K. Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients. Front Oncol 2021;11:631943. [PMID: 33767997 DOI: 10.3389/fonc.2021.631943] [Reference Citation Analysis]
20 Adnan A, Sheth RA. Image-guided Percutaneous Biopsy of the Liver. Tech Vasc Interv Radiol 2021;24:100773. [PMID: 34895710 DOI: 10.1016/j.tvir.2021.100773] [Reference Citation Analysis]
21 Neuberger J, Cain O. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. Hepat Med 2021;13:59-69. [PMID: 34163263 DOI: 10.2147/HMER.S278076] [Reference Citation Analysis]
22 Zherebtsov EA, Potapova EV, Mamoshin AV, Shupletsov VV, Kandurova KY, Dremin VV, Abramov AY, Dunaev AV. Fluorescence lifetime needle optical biopsy discriminates hepatocellular carcinoma. Biomed Opt Express 2022;13:633. [DOI: 10.1364/boe.447687] [Reference Citation Analysis]
23 Yoshiji H, Ueno Y, Kurosaki M, Torimura T, Hatano E, Yatsuhashi H, Yamakado K. Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures. Hepatol Res 2021;51:1181-95. [PMID: 34555262 DOI: 10.1111/hepr.13715] [Reference Citation Analysis]
24 Facciorusso A, Ramai D, Conti Bellocchi MC, Bernardoni L, Manfrin E, Muscatiello N, Crinò SF. Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience. Cancers (Basel) 2021;13:3062. [PMID: 34205389 DOI: 10.3390/cancers13123062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mendoza YP, Becchetti C, Watt KD, Berzigotti A. Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. Semin Liver Dis 2021. [PMID: 34243194 DOI: 10.1055/s-0041-1731705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Scharf RE. Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management. J Clin Med 2021;10:1530. [PMID: 33917431 DOI: 10.3390/jcm10071530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Borro P, Ziola S, Pasta A, Trombini M, Labanca S, Marenco S, Solarna D, Pisciotta L, Baldissarro I, Picciotto A, Dellepiane S. Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis. Ultrasound Med Biol 2021;47:947-59. [PMID: 33451815 DOI: 10.1016/j.ultrasmedbio.2020.12.015] [Reference Citation Analysis]
28 Scicali R, Di Pino A, Urbano F, Ferrara V, Marchisello S, Di Mauro S, Scamporrino A, Filippello A, Rabuazzo AM, Purrello F, Piro S. Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience. Nutrition, Metabolism and Cardiovascular Diseases 2021;31:869-79. [DOI: 10.1016/j.numecd.2020.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
29 Zeng K, Jiang Z, Yang J, Chen K, Lu Q. Role of endoscopic ultrasound-guided liver biopsy: a Meta-analysis. Scand J Gastroenterol 2022;:1-13. [PMID: 35049405 DOI: 10.1080/00365521.2021.2025420] [Reference Citation Analysis]
30 Kaufman CS, Cretcher MR. Transjugular Liver Biopsy. Tech Vasc Interv Radiol 2021;24:100795. [PMID: 34895709 DOI: 10.1016/j.tvir.2021.100795] [Reference Citation Analysis]
31 Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Frühbeck G, Dicker D, Woodward E, Korenjak M, Willemse J, Koek GH, Vinker S, Ungan M, Mendive JM, Lionis C. Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep 2021;3:100322. [PMID: 34693236 DOI: 10.1016/j.jhepr.2021.100322] [Reference Citation Analysis]
32 Seth S, Forrest EH, Morris JM, Heydtmann M, Konanahalli P, Kohnen G, Oien KA. Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient management. J Clin Pathol 2021:jclinpath-2020-207366. [PMID: 34039666 DOI: 10.1136/jclinpath-2020-207366] [Reference Citation Analysis]
33 Murgia A, Ahmed Y, Sweeney K, Nicholson-Scott L, Arthur K, Allsworth M, Boyle B, Gandelman O, Smolinska A, Ferrandino G. Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases. Biomedicines 2021;9:1563. [PMID: 34829792 DOI: 10.3390/biomedicines9111563] [Reference Citation Analysis]